C/O DENNIS M. LANFEAR, REDWOOD CITY, CA
Coherus Oncology Enters $50 Million Sales Agreement with Leerink Partners
Contingent Value Rights Agreement
Coherus Oncology Enters $55 Million Senior Secured Term Loan Agreement
Reports Second Quarter 2026 Financial Results and Provides Business Update
2026 Annual Meeting of Stockholders Voting Results - Coherus Oncology, Inc.
Reports First Quarter 2026 Financial Results and Provides Business Update
Annual Report to Security Holders
Financial Results, Press Release
Q2
FY 2025
Q3
Q1
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
PRE 14A
Definitive Proxy Statement
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Tender Offer Statement by Issuer
PREM14A
Submission Upload
Correspondence